-
公开(公告)号:US08076306B2
公开(公告)日:2011-12-13
申请号:US11734562
申请日:2007-04-12
CPC分类号: C12N15/113 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12N2310/3525
摘要: Disclosed herein are compounds, compositions and methods for modulating the expression of hepcidin in a cell, tissue or animal or preventing, ameliorating or treating anemia. Also provided are methods for prevention, amelioration or treatment of anemia, and for increasing red blood cell count in an animal. Also provided are methods for the prevention, amelioration and/or treatment of low serum iron levels, low red blood cell count and other clinical endpoints of anemia in an animal. These methods may be achieved by administration of compounds or compositions including antisense compounds targeted to a nucleic acid that expresses hepcidin polypeptide combined with an erythropoiesis stimulating agent.
摘要翻译: 本文公开了用于调节细胞,组织或动物中铁调素表达或预防,改善或治疗贫血的化合物,组合物和方法。 还提供了用于预防,改善或治疗贫血以及用于增加动物中红细胞计数的方法。 还提供了用于预防,改善和/或治疗动物体内低血清铁水平,低红细胞计数和贫血的其它临床终点的方法。 这些方法可以通过施用化合物或组合物来实现,所述化合物或组合物包括靶向表达与促红细胞生成刺激剂组合的铁调素多肽的核酸的反义化合物。
-
公开(公告)号:US20110112171A1
公开(公告)日:2011-05-12
申请号:US13009626
申请日:2011-01-19
申请人: Robert McKay , Ravi Jain , Kenneth W. Dobie , Sanjay K. Pandey , Sanjay Bhanot
发明人: Robert McKay , Ravi Jain , Kenneth W. Dobie , Sanjay K. Pandey , Sanjay Bhanot
IPC分类号: A61K31/7088 , A61P3/10 , A61P3/06 , A61P3/04 , A61P9/00
CPC分类号: C12N15/1137 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12Y301/03048 , C12N2310/3525
摘要: Disclosed herein are compounds, compositions and methods for modulating the expression of PTPRU in a cell, tissue or animal. Also provided are methods of active target segment validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Also provided are methods for the prevention, amelioration and/or treatment of diabetes, obesity, insulin resistance, insulin deficiency, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hyperfattyacidemia, liver steatosis, steatohepatitis, non-alcoholic steatohepatitis, metabolic syndrome, cardiovascular disease and coronary heart diseaseby administration of antisense compounds targeted to PTPRU.
摘要翻译: 本文公开了用于调节细胞,组织或动物中PTPRU表达的化合物,组合物和方法。 还提供了主动目标段验证的方法。 还提供了所公开的化合物和组合物在制备用于治疗疾病和病症的药物中的用途。 还提供了用于预防,改善和/或治疗糖尿病,肥胖症,胰岛素抵抗,胰岛素缺乏,高胆固醇血症,高血糖症,高脂血症,高甘油三酯血症,高脂肪肝,肝脂肪变性,脂肪性肝炎,非酒精性脂肪性肝炎,代谢综合征,心血管疾病和 通过给予靶向PTPRU的反义化合物的冠心病。
-
公开(公告)号:US07919476B2
公开(公告)日:2011-04-05
申请号:US11697280
申请日:2007-04-05
申请人: Sanjay Bhanot , Lynnetta Watts , Robert McKay , Susan M. Freier
发明人: Sanjay Bhanot , Lynnetta Watts , Robert McKay , Susan M. Freier
IPC分类号: A61K48/00
CPC分类号: C12N15/1138 , C07K14/705 , C07K14/723 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12N2310/3525
摘要: Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and treatment of disease associated with expression of glucagon receptor are provided.
摘要翻译: 提供化合物,组合物和方法用于调节胰高血糖素受体的表达。 组合物包含针对编码胰高血糖素受体的核酸的寡核苷酸。 提供了使用这些化合物调节胰高血糖素受体表达和用于诊断和治疗与胰高血糖素受体表达相关的疾病的方法。
-
公开(公告)号:US20110065775A1
公开(公告)日:2011-03-17
申请号:US12883049
申请日:2010-09-15
申请人: Sanjay Bhanot , Richard S. Geary , Robert McKay , Brett P. Monia , Punit P. Seth , Andrew M. Siwkowski , Eric E. Swayze , Edward Wancewicz
发明人: Sanjay Bhanot , Richard S. Geary , Robert McKay , Brett P. Monia , Punit P. Seth , Andrew M. Siwkowski , Eric E. Swayze , Edward Wancewicz
IPC分类号: A61K31/7052 , C07H21/00 , A61P3/00 , A61P3/04 , A61P3/10
CPC分类号: C12N15/113 , C12N15/1137 , C12N2310/11 , C12N2310/31 , C12N2310/315 , C12N2310/321 , C12N2310/322 , C12N2310/3231 , C12N2310/341 , C12N2310/3515 , C12Y203/0102 , C12N2310/3521
摘要: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
摘要翻译: 本公开描述了短反义化合物,包括长度为化学修饰的高亲和力单体8-16单体的这类化合物。 某些这样的短反义化合物可用于在增加的效力和改善的治疗指数的细胞,组织和动物中还原靶核酸和/或蛋白质。 因此,本文提供了包含用于在体内降低靶RNA的高亲和力核苷酸修饰的短反义化合物。 这样的短反义化合物在比以前描述的反义化合物低的剂量下是有效的,允许降低毒性和治疗成本。 此外,所述短反义化合物具有更大的口服给药潜力。
-
公开(公告)号:US20090326042A1
公开(公告)日:2009-12-31
申请号:US12299768
申请日:2007-05-07
申请人: Sanjay Bhanot , Richard Geary , Robert McKay , Brett P. Monia , Punit P. Seth , Andrew M. Siwkowski , Eric E. Swayze , Edward Wancewitz
发明人: Sanjay Bhanot , Richard Geary , Robert McKay , Brett P. Monia , Punit P. Seth , Andrew M. Siwkowski , Eric E. Swayze , Edward Wancewitz
IPC分类号: A61K31/7052 , C07H21/00 , C12N5/00 , A61P9/00
CPC分类号: C12N15/113 , C12N15/1137 , C12N2310/11 , C12N2310/31 , C12N2310/315 , C12N2310/321 , C12N2310/322 , C12N2310/3231 , C12N2310/341 , C12N2310/3515 , C12Y203/0102 , C12N2310/3521
摘要: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
摘要翻译: 本公开描述了短反义化合物,包括长度为化学修饰的高亲和力单体8-16单体的这类化合物。 某些这样的短反义化合物可用于在增加的效力和改善的治疗指数的细胞,组织和动物中还原靶核酸和/或蛋白质。 因此,本文提供了包含用于在体内降低靶RNA的高亲和力核苷酸修饰的短反义化合物。 这样的短反义化合物在比以前描述的反义化合物低的剂量下是有效的,允许降低毒性和治疗成本。 此外,所述短反义化合物具有更大的口服给药潜力。
-
公开(公告)号:US20090306005A1
公开(公告)日:2009-12-10
申请号:US12299572
申请日:2007-05-07
申请人: Sanjay Bhanot , Richard S. Geary , Robert McKay , Brett P. Monia , Punit P. Seth , Andrew M. Siwkowski , Eric Swayze , Edward Wancewicz
发明人: Sanjay Bhanot , Richard S. Geary , Robert McKay , Brett P. Monia , Punit P. Seth , Andrew M. Siwkowski , Eric Swayze , Edward Wancewicz
IPC分类号: A61K31/7088 , C07H21/00 , C12N5/02
CPC分类号: C12N15/113 , C12N15/1137 , C12N2310/11 , C12N2310/31 , C12N2310/315 , C12N2310/321 , C12N2310/322 , C12N2310/3231 , C12N2310/341 , C12N2310/3515 , C12Y203/0102 , C12N2310/3521
摘要: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
摘要翻译: 本公开描述了短反义化合物,包括长度为化学修饰的高亲和力单体8-16单体的这类化合物。 某些这样的短反义化合物可用于在增加的效力和改善的治疗指数的细胞,组织和动物中还原靶核酸和/或蛋白质。 因此,本文提供了包含用于在体内降低靶RNA的高亲和力核苷酸修饰的短反义化合物。 这样的短反义化合物在比以前描述的反义化合物低的剂量下是有效的,允许降低毒性和治疗成本。 此外,所述短反义化合物具有更大的口服给药潜力。
-
公开(公告)号:US07563884B2
公开(公告)日:2009-07-21
申请号:US11008747
申请日:2004-12-09
申请人: Lex M. Cowsert , Jacqueline R. Wyatt , Susan M. Freier , Brett P. Monia , Madeline M. Butler , Robert McKay
发明人: Lex M. Cowsert , Jacqueline R. Wyatt , Susan M. Freier , Brett P. Monia , Madeline M. Butler , Robert McKay
CPC分类号: C12N15/1137 , A61K38/00 , A61K48/00 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/345 , C12N2310/346 , C12Y301/03048 , Y02P20/582 , C12N2310/3525
摘要: Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.
-
公开(公告)号:US20090124009A1
公开(公告)日:2009-05-14
申请号:US12046421
申请日:2008-03-11
申请人: Sanjay Bhanot , Lex M. Cowsert , Jacqueline R. Wyatt , Brett P. Monia , Madelline M. Butler , Robert McKay , Susan M. Freier , Kenneth W. Dobie
发明人: Sanjay Bhanot , Lex M. Cowsert , Jacqueline R. Wyatt , Brett P. Monia , Madelline M. Butler , Robert McKay , Susan M. Freier , Kenneth W. Dobie
IPC分类号: C12N5/08 , C07H21/04 , A61K31/711
CPC分类号: C12N15/113 , A61K38/00 , A61K48/00 , C12N15/1137 , C12N2310/11 , C12N2310/14 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/345 , C12N2310/346 , C12Y301/03048 , Y02P20/582 , C12N2310/3525
摘要: Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.
摘要翻译: 提供化合物,组合物和方法用于调节PTP1B的表达。 组合物包含靶向编码PTP1B的核酸的反义化合物,特别是反义寡核苷酸。 提供了使用这些化合物调节PTP1B表达和治疗与PTP1B表达相关的疾病的方法。
-
公开(公告)号:US20080153767A1
公开(公告)日:2008-06-26
申请号:US11739017
申请日:2007-04-23
申请人: Kenneth W. Dobie , Sanjay Bhanot , Murielle Veniant-Ellison , Richard A. Lindberg , John R. Shutter , Robert McKay , Sanjay K. Pandey
发明人: Kenneth W. Dobie , Sanjay Bhanot , Murielle Veniant-Ellison , Richard A. Lindberg , John R. Shutter , Robert McKay , Sanjay K. Pandey
CPC分类号: C12N15/113 , A61K38/00 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , Y02P20/582 , C12N2310/3525
摘要: Antisense compounds, compositions and methods are provided for modulating the expression of forkhead box O1A. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding forkhead box O1A. Methods of using these compounds for modulation of forkhead box O1A expression and for treatment of diseases associated with expression of forkhead box O1A are provided, in particular, for methods of treating diabetes.
摘要翻译: 提供反义化合物,组合物和方法用于调节叉头盒O1A的表达。 组合物包含靶向编码叉头盒O1A的核酸的反义化合物,特别是反义寡核苷酸。 提供使用这些化合物调制叉头盒O1A表达和用于治疗与叉头盒O1A的表达相关的疾病的方法,特别是用于治疗糖尿病的方法。
-
公开(公告)号:US20080000171A1
公开(公告)日:2008-01-03
申请号:US11424839
申请日:2006-06-16
申请人: Jodi McKay , Robert McKay , Brett Rhinehardt , Daniel Lee Bizzell , Ian D. Kovacevich , Tom Philpott
发明人: Jodi McKay , Robert McKay , Brett Rhinehardt , Daniel Lee Bizzell , Ian D. Kovacevich , Tom Philpott
IPC分类号: A47F10/00
摘要: A portable workstation includes wheels, a tabletop, a generally planar member and a chassis joining the wheels, the tabletop and the planar member. While joined to the wheels and the tabletop by the chassis, the planar member is movable between a protracted position and a retracted position. A majority of the planar member extends above the tabletop in the protracted position, and a majority of the planar member does not extend above the tabletop in the retracted position.
摘要翻译: 便携式工作站包括车轮,桌面,大致平面的构件和连接车轮,台面和平面构件的底盘。 当通过底盘连接到车轮和桌面时,平面构件可在延伸位置和缩回位置之间移动。 平面构件的大部分在延伸位置上延伸到台面之上,并且平面构件的大部分在缩回位置不延伸到台面之上。
-
-
-
-
-
-
-
-
-